New CEOs at Dualitas, Apnimed, Vergent and Oriva: Management Tracks

A long list of biotech companies introduced new CEOs in recent days, including private companies Dualitas Therapeutics Inc., Apnimed Inc., Vergent Bioscience Inc. and Oriva Therapeutics S.L.

Well-funded single-asset company Ambros Therapeutics Inc. brought in CFO Cris Calsada and SVP of Clinical Operations and Program Management Claire Padgett as it conducts a Phase III study of its lead program for complex regional pain syndrome type 1 (CRPS-1). Both held similar titles at Regulus Therapeutics Inc., which Novartis AG (SIX:NOVN; NYSE:NVS) acquired...